Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-16-001361
Filing Date
2016-02-08
Accepted
2016-02-08 08:15:50
Documents
68
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. 10Q 2015-12-31 aoxing10q.htm 10-Q 527860
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 exh311.htm EX-31.1 7468
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 exh312.htm EX-31.2 7458
4 CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350. exh321.htm EX-32.1 4406
5 CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350. exh322.htm EX-32.2 4531
  Complete submission text file 0001096906-16-001361.txt   2674806

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axn-20151231.xml EX-101.INS 537831
7 XBRL TAXONOMY EXTENSION SCHEMA axn-20151231.xsd EX-101.SCH 31837
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE axn-20151231_cal.xml EX-101.CAL 30256
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE axn-20151231_def.xml EX-101.DEF 40586
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE axn-20151231_lab.xml EX-101.LAB 154812
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axn-20151231_pre.xml EX-101.PRE 140608
Mailing Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404
Business Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-32674 | Film No.: 161394113
SIC: 2834 Pharmaceutical Preparations